Clinical trial Recruiting at 1 site Observational

Registry for patients with CABP2-related hearing impairment

Official title: Patient Registry for Individuals With CABP2-Associated Hearing Loss

Run by University Medical Center Goettingen · NCT06680934 · Data updated 2026-11-12

This study is collecting information from people with hearing loss caused by CABP2 gene changes to learn more about this condition and how it affects them.

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorUniversity Medical Center Goettingen
Academic / other
Locations1 site (Göttingen)
StatusRecruiting
StartedAugust 16, 2024
Main results expectedAugust 16, 2049
Study endsAugust 16, 2049
Registry record updatedJanuary 27, 2026
Trial IDNCT06680934 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a confirmed molecular genetic diagnosis of biallelic variants in the CABP2 gene and associated audiometry results.

Probably not a fit

Patients with hearing impairment due to non-CABP2 genetic causes will not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects detailed information about individuals diagnosed with hearing impairment due to CABP2 gene variants. It aims to gather molecular genetic data and clinical information to support a natural history study of this condition. The study is conducted in both German and English and adheres to ethical guidelines approved by the University Medical Center Goettingen's Ethics Committee.

Why it matters

Potential benefit: If successful, this registry could enhance understanding of CABP2-related hearing impairment and improve patient management.

How similar studies have gone: While this registry approach is common in genetic research, the specific focus on CABP2-related auditory synaptopathy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry

Exclusion Criteria:

* Patients with evidence of non-CABP2 molecular genetic diagnoses

Where it's running

  • University Medical Center Goettingen
    Göttingen, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.